ASPI ASP Isotopes Inc.
Price Chart
Executive Summary
ASP Isotopes announced it successfully restarted the first 18 stages (segments one and two) of its Silicon-28 enrichment facility in Pretoria, South Africa, after nine months of engineering enhancements to non-core components (valves, compressors, piping). The company expects initial commercial shipments of enriched Silicon-28 to U.S. customers in Q3 2026, building on three previously announced supply contracts and independent confirmation that earlier sample enrichment levels tracked theoretical calculations.
Actionable Insight
This is a material derisking event for ASPI's Silicon-28 commercialization pathway. Successful steady-state operation of 18 stages and a Q3 2026 commercial shipment target are concrete milestones beyond prior 'first samples' stage. Monitor for updates on remaining stages commissioning and any customer announcements that could confirm revenue timing — the three existing contracts suggest committed demand. However, ASPI remains pre-revenue with no financials in this filing; the stock has historically been volatile with a negative T+20 win rate (38%), so position sizing should account for execution risk on the full facility ramp.
Key Facts
- First 18 stages of Silicon-28 enrichment facility successfully restarted and operated for over three weeks at target enrichment levels.
- Engineering modifications over the past nine months addressed non-core components (valves, compressors, piping); same enhancements to be applied to remaining stages.
- Initial commercial shipments of enriched Silicon-28 expected to commence in Q3 2026.
- Three commercial contracts for enriched Silicon-28 previously signed with U.S.-based customers.
- First samples shipped to a U.S. customer in August 2025; independent analysis confirmed enrichment levels tracked in line with theoretical calculations.
- Enriched Silicon-28 applications cited for quantum computing (qubit coherence) and next-gen semiconductor thermal management.
Financial Impact
No financial figures disclosed — revenue, contract values, and unit economics are not in the filing.
Risk Factors
- Remaining stages of the enrichment facility still require implementation of engineering modifications — no timeline given for full completion.
- Commercial production scale-up remains subject to operational, regulatory, and geopolitical risks in South Africa.
- Pre-revenue company with no disclosed contract values or revenue; financial viability depends on successful commercialization.
- Historical stock performance shows high volatility and negative average T+20 alpha (-5.43%) despite neutral/bullish catalysts, suggesting sell-on-news patterns.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-237916 |
| Document: aspi-ex99_1.htm | 0001193125-26-237916 |
| Document: 0001193125-26-237916-index-headers.html | 0001193125-26-237916 |
| Document: 0001193125-26-237916-index.html | 0001193125-26-237916 |
| Document: 0001193125-26-237916.txt | 0001193125-26-237916 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
3d ago
|
Institutional Cluster
| $6.22 awaiting T+1 | awaiting T+1 | — | $6.55 (+5.31%) |
|
Jun 2, 2026
13d ago
|
144
| $8.33 $7.55 | ▼ −9.36% | ▼ −8.64% | $6.55 (−21.37%) |
|
May 26, 2026
19d ago
|
8-K
| $6.93 $6.67 | ▼ −3.75% | ▼ −3.77% | $6.55 (−5.48%) |
|
May 20, 2026
25d ago
|
8-K
| $5.17 $5.55 | ▲ +7.35% | ▲ +6.90% | $6.55 (+26.69%) |
|
May 11, 2026
4w ago
|
8-K
| $6.22 $5.97 | ▼ −4.02% | ▼ −3.88% | $6.55 (+5.31%) |
|
Apr 18, 2026
8w ago
|
144
| $5.47 $5.06 | ▼ −7.50% | ▼ −6.84% | $6.55 (+19.74%) |
|
Apr 13, 2026
8w ago
|
8-K
| $5.06 $5.00 | ▼ −1.19% | ▼ −2.40% | $6.55 (+29.45%) |
|
Apr 10, 2026
9w ago
|
8-K
| $4.48 $5.06 | ▲ +12.95% | ▲ +11.97% | $6.55 (+46.21%) |
|
Mar 24, 2026
11w ago
|
Press Release
| $4.98 $5.04 | ▲ +1.20% | ▲ +0.64% | $6.55 (+31.53%) |
|
Mar 6, 2026
14w ago
|
Press Release
| $5.55 $5.81 | ▲ +4.68% | ▲ +3.84% | $6.55 (+18.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access